play_arrow

keyboard_arrow_right

Listeners:

Top listeners:

skip_previous skip_next
00:00 00:00
playlist_play chevron_left
volume_up

Vaccine manufacturing

3 Results / Page 1 of 1

Background

Health / Medical

Africa races to increase vaccine manufacturing capacity, concerns rise over Europe’s control

          By Conrad Onyango, bird story agency     As Africa races to be more independent in vaccine production, Europe is seeking greater control in building and scaling of local manufacturing hubs. In June, France hosted the launch of African Vaccine Manufacturing Accelerator (AVMA) an approximately US$1 billion project geared towards making vaccines more available in Africa - away from African soil. Only 2% of vaccines […]

todayJuly 2, 2024 43

Africa

Gavi approves $1.8B African vaccine manufacturing accelerator for self-reliance

By Bonface Orucho, bird story agency Recent approval by the Vaccine Alliance (Gavi) of a US$1.8 billion African Vaccine Manufacturing Accelerator (AVMA), a financing instrument that will support sustainable vaccine manufacturing in Africa is being hailed as a game changer for the continent. “The targeted US$1 billion from Gavi to African manufacturers is a game changer for the continent and advances our efforts towards vaccine self-reliance,” said Jean Kaseya, Africa […]

todayDecember 21, 2023 36

Malaria

Africa

Malaria: two groundbreaking vaccines have been developed, but access and rollout are still big stumbling blocks

By Rose Leke, Université de Yaounde 1 The approval of two malaria vaccines – the RTS,S/AS01 vaccine in 2021 and the R21/Matrix-MTM vaccine in 2023 – will help control, and eventually help eradicate, a disease that causes more than 600,000 deaths annually. Nearly 2 million children in Ghana, Kenya and Malawi have been vaccinated with the RTS,S/AS01 vaccine. It will be rolled out to more African countries from early next year. […]

todayNovember 23, 2023 6

0%